Ask AI
ProCE Banner Activity

Resistant Hypertension: Controlling the Uncontrollable With New and Emerging Therapies

Clinical Thought

Learn what novel therapies are being studied for treating patients with resistant hypertension and how these therapies’ targeted mechanisms of action are filling current gaps in care.

Released: August 14, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca Pharmaceuticals.

AstraZeneca Pharmaceuticals

Disclosure

Primary Author

Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA (hon.): consultant/advisor/speaker: Amgen, Boehringer Ingelheim, Janssen, Novartis, Medtronic.